Table 3 Adverse events in MP group and control group
Adverse events | MP group (n = 57) | Control group (n = 54) | P value |
|---|---|---|---|
Infection | 28 | 26 | 1.000 |
 bacteria | 19 | 18 | 1.000 |
 fungus | 4 | 3 | 1.000 |
 virus | 5 | 5 | 1.000 |
Thrombocytopenia | 13 | 9 | 0.480 |
Leukopenia | 8 | 5 | 0.559 |
Diabetes | 4 | 5 | 0.738 |
Gastrointestinal | 4 | 4 | 1.000 |
Cardiovascular | 2 | 5 | 0.263 |
Hemorrhage | 3 | 3 | 1.000 |
Bone fracture | 0 | 1 | 0.486 |
Vascular access complication | 0 | 1 | 0.486 |
Epilepsy | 1 | 0 | 1.000 |
Cataract | 0 | 1 | 0.486 |
Totals | 63 | 60 | Â |